Medicenna Therapeutics Corp.
MDNA.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 827.10K | -3.71M | -3.05M | -2.66M | -10.31M |
| Total Depreciation and Amortization | 13.20K | 12.90K | 8.10K | 3.70K | 700.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.99M | 770.10K | -240.50K | 263.80K | 7.33M |
| Change in Net Operating Assets | 671.00K | 385.80K | -830.00K | 689.10K | -609.70K |
| Cash from Operations | -3.48M | -2.54M | -4.12M | -1.70M | -3.59M |
| Capital Expenditure | 0.00 | 0.00 | -1.50K | -22.70K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -1.50K | -22.70K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 1.91M | 1.01M | 20.90M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -300.00K | -- | -- |
| Cash from Financing | -13.20K | 1.36M | 517.60K | 15.27M | -- |
| Foreign Exchange rate Adjustments | -100.30K | 869.40K | -215.60K | 79.70K | 51.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.59M | -307.20K | -3.81M | 13.63M | -3.54M |